[HTML][HTML] Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics

KR Gajbhiye, R Salve, M Narwade, A Sheikh… - Molecular Cancer, 2023 - Springer
Lipid-based polymeric nanoparticles are the highly popular carrier systems for cancer drug
therapy. But presently, detailed investigations have revealed their flaws as drug delivery …

Recent advances in multifunctional dendrimer‐based complexes for cancer treatment

D Shcharbin, V Zhogla, V Abashkin… - Wiley …, 2024 - Wiley Online Library
The application of nanotechnology in biological and medical fields have resulted in the
creation of new devices, supramolecular systems, structures, complexes, and composites …

Dendrimer platform against prostate cancer: Recent update on new horizon of treatment

M Pandey, HX Lang, JS Loh, YL Chai, HL Tee… - Journal of Drug Delivery …, 2023 - Elsevier
Prostate malignancy is regarded as one of the most lethal disorders in men. In the last two
decades, new cases of prostate cancer have risen swiftly worldwide. Currently, the …

Nanotherapeutics for prostate cancer treatment: A comprehensive review

R Hu, J Lan, D Zhang, W Shen - Biomaterials, 2024 - Elsevier
Prostate cancer (PCa) is the most prevalent solid organ malignancy and seriously affects
male health. The adverse effects of prostate cancer therapeutics can cause secondary …

Programmed nanocarrier loaded with paclitaxel and dual-siRNA to reverse chemoresistance by synergistic therapy

M Zhang, X Zhang, S Huang, Y Cao, Y Guo… - International Journal of …, 2024 - Elsevier
Paclitaxel (PTX) is commonly used in clinical tumor therapy. However, chemoresistance and
the inducement of tumor metastasis severely affect the efficacy of PTX. To develop a …

αvβ3 integrin-targeted pH-responsive dendritic nanocarriers for enhanced anti-tumor efficacy of docetaxel against breast cancer

S Korake, R Salve, V Gajbhiye, A Pawar - Journal of Drug Delivery Science …, 2024 - Elsevier
The hyperbranched biodegradable dendrimer (Boltron® H40) has received mounting
attention as a result of its efficient encapsulation of therapeutic molecules and sustained …

MUC1 aptamer-tethered H40-TEPA-PEG nanoconjugates for targeted siRNA-delivery and gene silencing in breast cancer cells

R Salve, N Haldar, A Shaikh, R Samanta… - … in Bioengineering and …, 2024 - frontiersin.org
With a prevalence of 12.5% of all new cancer cases annually, breast cancer stands as the
most common form of cancer worldwide. The current therapies utilized for breast cancer are …

[PDF][PDF] Initial version before any revisions

D Shcharbin, V Zhogla, V Abashkin, Y Gao, JP Majoral… - researchgate.net
The application of nanotechnology in biology and medicine induced the appearance of new
devices, supramolecular systems, structures, complexes and composites. Dendrimers are …